Eiko Lifesciences Ltd Stock Price Today (NSE: EIKO)
Fundamental Score
Eiko Lifesciences Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Eiko Lifesciences Ltd share price today is ₹52.95, up +1.20% on NSE/BSE as of 19 June 2026. Eiko Lifesciences Ltd (EIKO) is a Small-cap company in the Specialty Chemicals sector with a market capitalisation of ₹69.89 (Cr). The 52-week high for EIKO share price is ₹65.90 and the 52-week low is ₹45.90. At a P/E ratio of 21.63x, EIKO is currently trading below its industry average P/E of 29.20x.
Eiko Lifesciences Ltd Share Price Chart — NSE/BSE Historical Performance
Eiko Lifesciences Ltd share price chart: 6.28% return over the past month. 52-week high ₹65.90, 52-week low ₹45.90.
Eiko Lifesciences Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹52.87 | ₹53.95 | ₹51.16 | ₹52.95 | 11.31K (Cr) | |
| ₹53.44 | ₹53.44 | ₹51.00 | ₹52.32 | 9.37K (Cr) | |
| ₹54.00 | ₹54.60 | ₹52.02 | ₹52.15 | 17.79K (Cr) | |
| ₹53.98 | ₹56.35 | ₹53.02 | ₹53.31 | 40.20K (Cr) | |
| ₹49.93 | ₹55.90 | ₹49.85 | ₹53.03 | 80.93K (Cr) | |
| ₹49.20 | ₹49.55 | ₹48.65 | ₹49.38 | 10.16K (Cr) | |
| ₹49.17 | ₹49.89 | ₹49.17 | ₹49.57 | 1.25K (Cr) | |
| ₹49.80 | ₹50.80 | ₹48.99 | ₹49.48 | 25.64K (Cr) | |
| ₹49.58 | ₹49.94 | ₹49.00 | ₹49.05 | 5.95K (Cr) | |
| ₹49.06 | ₹50.49 | ₹49.01 | ₹49.75 | 2.25K (Cr) |
Eiko Lifesciences Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹53.44 | ₹53.95 | ₹51.00 | ₹52.95 | -0.92% | |
| ₹50.46 | ₹56.35 | ₹48.00 | ₹52.15 | +3.35% | |
| ₹50.98 | ₹55.00 | ₹49.00 | ₹50.46 | -1.02% | |
| ₹52.50 | ₹55.88 | ₹45.90 | ₹49.74 | -5.26% | |
| ₹54.66 | ₹54.66 | ₹49.00 | ₹51.46 | -5.85% | |
| ₹54.00 | ₹55.98 | ₹48.02 | ₹53.90 | -0.19% | |
| ₹52.30 | ₹59.00 | ₹48.00 | ₹55.05 | +5.26% | |
| ₹58.00 | ₹64.44 | ₹50.00 | ₹52.14 | -10.10% | |
| ₹53.25 | ₹57.99 | ₹49.86 | ₹56.35 | +5.82% | |
| ₹51.05 | ₹57.90 | ₹50.56 | ₹53.25 | +4.31% | |
| ₹57.50 | ₹57.50 | ₹51.00 | ₹51.22 | -10.92% | |
| ₹49.56 | ₹65.90 | ₹48.21 | ₹56.51 | +14.02% |
AI Research Briefing
Powered by Gemini · 2026-04-08
Eiko is a microcap gamble on the successful integration of a single, potentially transformative acquisition.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Eiko Lifesciences' trading window closed on April 1st, 2026, in anticipation of the year-end financial results. The stock is down -23.6% from its 52-week high.
CORE STORY (THE REAL GAME)
Eiko is trying to transform from a specialty chemical and API supplier into an integrated pharma player. The market's watching if they can execute the SSM Formulations acquisition and scale up finished dosage production.
- SSM Formulations acquisition approved in Dec 2025
- Q3 profit surge of 239.29%
- Trading window closed ahead of results
- Successful integration of SSM Formulations
- Significant order wins in formulations
- Capacity expansion at SSM facility
- Microcap liquidity risk
- Integration risk of SSM
- Reliance on single acquisition for growth
Promoter holding increased slightly by 0.43%. No FII/DII activity.
Indian specialty chemicals sector projected to grow, but faces global economic uncertainty and high energy costs.
Free Cash Flow 5Y: ₹None Cr suggests poor cash conversion.
Eiko's 3-6 month outlook depends on the successful integration of SSM Formulations and ability to scale up production. Failure to do so will result in a significant correction.
Primary Thesis Risk
Failure to integrate SSM Formulations will obliterate the bull case.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Eiko Lifesciences Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Eiko Lifesciences Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of EIKO across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Attractive Valuation (P/E: 21.63 vs Industry: 29.20)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (285.71%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (43.01%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (29.35% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (20.61% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (25.18% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.02)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (20.84x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
1 factors identified
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Eiko Lifesciences Ltd vs Specialty Chemicals Peers
Peer Comparison - Specialty Chemicals
Compare Eiko Lifesciences Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Eiko Lifesciences LtdEiko Lifescienc...Selected✓ EIKO • 540204 | 51/100 | ₹52.95₹53 | ₹69.89₹69.89 | 21.63Average 21.6 Average | — — | — — | 0.02Excellent 0.0 Excellent | 25.18%Excellent 25.18% Excellent | 29.35%Excellent 29.35% Excellent | 0.00% |
Pidilite Industries LimitedPidilite Indust... PIDILITIND • 500331 | 60.4/100 | ₹1457.20₹1457 | ₹149466.57₹149466.57 | 66.59Average 66.6 Average | 23.05%Excellent 23.05% Excellent | 29.84%Excellent 29.84% Excellent | 0.05Excellent 0.1 Excellent | 12.63%Good 12.63% Good | 12.49%Good 12.49% Good | 0.68% |
Gujarat Fluorochemicals LtdGujarat Fluoroc... FLUOROCHEM • 542812 | 51.5/100 | ₹3612.00₹3612 | ₹37241.99₹37241.99 | 54.77Average 54.8 Average | 8.29%Poor 8.29% Poor | 9.89%Poor 9.89% Poor | 0.23Excellent 0.2 Excellent | 21.05%Excellent 21.05% Excellent | 12.69%Good 12.69% Good | 0.09% |
Navin Fluorine International LtdNavin Fluorine ... NAVINFLUOR • 532504 | 40.6/100 | ₹6998.50₹6999 | ₹29462.02₹29462.02 | 66.34Average 66.3 Average | 11.52%Average 11.52% Average | 11.68%Average 11.68% Average | 0.33Excellent 0.3 Excellent | -6.59%Poor -6.59% Poor | 17.22%Excellent 17.22% Excellent | 0.21% |
Deepak Nitrite LtdDeepak Nitrite ... DEEPAKNTR • 506401 | 40.2/100 | ₹1670.10₹1670 | ₹21083.64₹21083.64 | 39.67Average 39.7 Average | 13.36%Average 13.36% Average | 16.28%Good 16.28% Good | 0.23Excellent 0.2 Excellent | 2.02%Average 2.02% Average | 14.38%Good 14.38% Good | 0.49% |
BASF India LtdBASF India Ltd... BASF • 500042 | 52/100 | ₹3330.20₹3330 | ₹17807.40₹17807.40 | 46.29Average 46.3 Average | 13.73%Average 13.73% Average | 18.02%Good 18.02% Good | 0.04Excellent 0.0 Excellent | 57.98%Excellent 57.98% Excellent | 14.83%Good 14.83% Good | 0.49% |
Atul LtdAtul Ltd... ATUL • 500027 | 50.5/100 | ₹6685.50₹6686 | ₹17066.13₹17066.13 | 31.47Average 31.5 Average | 9.10%Poor 9.10% Poor | 12.81%Average 12.81% Average | 0.03Excellent 0.0 Excellent | -5.82%Poor -5.82% Poor | 6.41%Good 6.41% Good | 0.43% |
Vinati Organics LtdVinati Organics... VINATIORGA • 524200 | 57.2/100 | ₹1307.20₹1307 | ₹16256.72₹16256.72 | 34.97Average 35.0 Average | 15.75%Good 15.75% Good | 20.61%Excellent 20.61% Excellent | 0.00Excellent 0.0 Excellent | 4.46%Average 4.46% Average | 16.92%Excellent 16.92% Excellent | 0.48% |
Anupam Rasayan India LtdAnupam Rasayan ... ANURAS • 543275 | 37.5/100 | ₹1328.20₹1328 | ₹14036.52₹14036.52 | 92.84Average 92.8 Average | 3.32%Poor 3.32% Poor | 7.33%Poor 7.33% Poor | 0.38Excellent 0.4 Excellent | 11.97%Good 11.97% Good | 22.13%Excellent 22.13% Excellent | 0.06% |
Aarti Industries LtdAarti Industrie... AARTIIND • 524208 | 41.9/100 | ₹470.90₹471 | ₹13796.68₹13796.68 | 51.29Average 51.3 Average | 6.03%Poor 6.03% Poor | 6.32%Poor 6.32% Poor | 0.70Good 0.7 Good | -9.09%Poor -9.09% Poor | 11.68%Good 11.68% Good | 0.26% |
Fine Organic Industries LtdFine Organic In... FINEORG • 541557 | 60.5/100 | ₹4491.60₹4492 | ₹13359.76₹13359.76 | 33.38Average 33.4 Average | 19.47%Good 19.47% Good | 26.39%Excellent 26.39% Excellent | 0.01Excellent 0.0 Excellent | 20.04%Excellent 20.04% Excellent | 16.93%Excellent 16.93% Excellent | 0.25% |
Top Specialty Chemicals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Pidilite Industries Limited share price149466.57 Cr
- Gujarat Fluorochemicals Ltd share price37241.99 Cr
- Navin Fluorine International Ltd share price29462.02 Cr
- Deepak Nitrite Ltd share price21083.64 Cr
- BASF India Ltd share price17807.40 Cr
Eiko Lifesciences Ltd PE Ratio History
Historical price-to-earnings ratio for EIKO — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹1.62 | ₹55.05 | 34x |
| FY 2024 | ₹0.73 | ₹62.74 | 85.9x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Eiko Lifesciences Ltd Quarterly Performance
Latest quarterly metrics for EIKO — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
43.01%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
285.71%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
29.35%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
25.18%
Compounded annual net profit growth over 5 years
Eiko Lifesciences Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for EIKO — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Eiko Lifesciences Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Eiko Lifesciences Ltd (EIKO) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Eiko Lifesciences Ltd
About EIKO (Eiko Lifesciences Ltd)
Eiko Lifesciences Ltd is a dynamic force in the specialty chemicals arena, meticulously crafting high-value ingredients and solutions for diverse global industries. Focused on prec...ision and innovation, EIKO leverages cutting-edge research and development to synthesize complex molecules, catering to niche applications where quality and performance are paramount. From specialized agrochemical components that enhance crop yields to advanced pharmaceutical intermediates that accelerate drug discovery, EIKO's comprehensive portfolio is designed to meet the evolving needs of its discerning clientele. The company prides itself on its commitment to sustainable practices, employing green chemistry principles to minimize environmental impact throughout its manufacturing processes. EIKO's strategic divisions synergistically operate, contributing to a robust and vertically integrated business model. The agrochemical division develops novel chemistries for crop protection, while the pharmaceutical arm synthesizes critical intermediates for drug formulations. EIKO's foray into oleo chemicals allows the company to offer bio-based solutions derived from natural oils and fats. In food additives, the organization is actively in manufacturing high-quality ingredients to boost and improve food production. Moreover, the company's dedication extends beyond production, encompassing comprehensive services such as research, development, logistics, and efficient distribution channels. This holistic approach ensures seamless delivery of tailored solutions to clients across geographical boundaries. Driven by a customer-centric philosophy, EIKO invests heavily in building strong, collaborative partnerships. The company's team of experienced chemists and engineers works closely with clients, providing technical support, customized formulations, and reliable supply chain management. EIKO's commitment to quality is unwavering, adhering to stringent regulatory standards and employing rigorous quality control measures at every stage of production. Through continuous innovation, operational excellence, and a steadfast dedication to customer satisfaction, EIKO is poised to further solidify its position as a trusted and reliable provider of specialty chemicals worldwide.
Company Details
Key Leadership
Corporate Events
Latest News
EIKO Share Price: Frequently Asked Questions
What is the current share price of Eiko Lifesciences Ltd?
Eiko Lifesciences Ltd (EIKO) trades at ₹52.95 on NSE and BSE. Market cap ₹69.89 (Cr). Educational data only.
What is the P/E ratio of Eiko Lifesciences Ltd?
Eiko Lifesciences Ltd has a P/E of 21.63x vs industry average 29.20x.
What is the Bull Run score for Eiko Lifesciences Ltd?
Eiko Lifesciences Ltd has a Bull Run score of 51/100 based on 25+ financial parameters.
Does Eiko Lifesciences Ltd pay dividends?
Eiko Lifesciences Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Eiko Lifesciences Ltd?
Eiko Lifesciences Ltd has ROE of N/A. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Eiko Lifesciences Ltd?
Eiko Lifesciences Ltd has debt-to-equity of 0.02.
Is Eiko Lifesciences Ltd a good investment?
Bull Run gives Eiko Lifesciences Ltd a score of 51/100. This is not investment advice — consult a SEBI-registered advisor.